Internal Medicine Speclsts entered the industry of Health Services in 2012 and has grown to employ 1 to 4 people, generating an annual revenue of $1.000.000 to $2.499.999. The NAICS classifies this business under the code 6211110, which describes it as a Health Services. For further clarification, the SIC classifies this business under the code 8099 and described it as a Health Services. The business provides service to the B2C market.
To acquire more information, please contact Suzanne Alkarra, Office Manager by calling (409) 908-9345 during business hours. You can also write to the business’ Single Location at 6807 Emmett F Lowry Expressway # 310, Texas City, Texas TX 77591. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .
Company: | Internal Medicine Speclsts |
Representative: | Suzanne Alkarra, Office Manager |
Place of Business: | 6807 Emmett F Lowry Expressway # 310, Texas City, TX 77591 |
Contact Number: | (409) 908-9345 |
Type of Service: | Health Services |
SIC Number: | 8099 |
NAICS Number: | 6211110 |
Locality: | Single Location |
Market Type: | B2C (Business to Consumer) |
Began: | 2012 |
Income/Year: | $1.000.000 to $2.499.999 |
Laborers: | 1 to 4 |
Share This Company: |
Internal Medicine Speclsts is a company operating from Galveston, Texas providing professional Health Services and relevant B2C variables. It was founded in 2012 and registered with the SIC code 8099 as Health Services, and with the NAICS code 6211110 as Health Services.
With a current employee count of 1 to 4, Internal Medicine Speclsts has gone to report making $1.000.000 to $2.499.999 per annum on its journey towards growth. This company invites you to contact its representative Suzanne Alkarra, Office Manager at (409) 908-9345 for related queries, or to locate its Single Location using the coordinates 29.39525,-94.9874.
The Single Location can also be found at the street address 6807 Emmett F Lowry Expressway # 310 in Texas City, Texas 77591 and can be engaged online through the company website at , the company Twitter , and Facebook page .